941
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluations

A review of the use of fluticasone furoate since its launch

, , & , MD
Pages 2107-2117 | Published online: 29 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Piotr Damiański, Grzegorz Kardas, Michał Panek, Piotr Kuna & Maciej Kupczyk. (2022) Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions. Expert Opinion on Drug Safety 21:4, pages 499-515.
Read now
Luigino Calzetta, Barbara Rinaldi, Mario Cazzola & Maria Gabriella Matera. (2016) Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 813-822.
Read now
Lígia Peralta & Paulo Morais. (2012) Perioral dermatitis – the role of nasal steroids. Cutaneous and Ocular Toxicology 31:2, pages 160-163.
Read now

Articles from other publishers (9)

Andrea Rizzi, Gabriele Amari, Fausto Pivetti, Maurizio Delcanale, Francesco Amadei, Alice Pappani, Luca Fornasari, Gino Villetti, Gessica Marchini, Anna Rita Pisano, Vanessa Pitozzi, Maria Gloria Pittelli, Marcello Trevisani, Michela Salvadori, Valentina Cenacchi, Alessandro Fioni, Paola Puccini, Maurizio Civelli, Riccardo Patacchini, Charles Baker-Glenn, Hervé Van de Poël, Wesley Blackaby, Kevin Nash & Elisabetta Armani. (2023) Optimization of M 3 Antagonist–PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD . Journal of Medicinal Chemistry.
Crossref
Adrian HobsonAdrian Hobson. 2023. The Medicinal Chemistry of Glucocorticoid Receptor Modulators. The Medicinal Chemistry of Glucocorticoid Receptor Modulators 25 36 .
Yuanzheng HeJingjing ShiQuang Tam NguyenErli YouHongbo LiuXin RenZhongshan WuJianshuang LiWenli QiuSok Kean KhooTao YangWei Yi, Feng SunZhijian XiXiaozhu HuangKarsten Melcher, Booki MinH. Eric Xu. (2019) Development of highly potent glucocorticoids for steroid-resistant severe asthma. Proceedings of the National Academy of Sciences 116:14, pages 6932-6937.
Crossref
Eleonora Ghidini, Gessica Marchini, Anna Maria Capelli, Chiara Carnini, Valentina Cenacchi, Alessandro Fioni, Fabrizio Facchinetti & Fabio Rancati. (2018) Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases. Journal of Medicinal Chemistry 61:11, pages 4757-4773.
Crossref
Yuanzheng He, Jingjing Shi, Wei Yi, Xin Ren, Xiang Gao, Jianshuang Li, Nanyan Wu, Kevin Weaver, Qian Xie, Sok Kean Khoo, Tao Yang, Xiaozhu Huang, Karsten Melcher & H Eric Xu. (2015) Discovery of a highly potent glucocorticoid for asthma treatment. Cell Discovery 1:1.
Crossref
Ilse M. Beck, Koen Van Crombruggen, Gabriele Holtappels, François Daubeuf, Nelly Frossard, Claus Bachert & Karolien De Bosscher. (2015) Differential Cytokine Profiles upon Comparing Selective versus Classic Glucocorticoid Receptor Modulation in Human Peripheral Blood Mononuclear Cells and Inferior Turbinate Tissue. PLOS ONE 10:4, pages e0123068.
Crossref
Joaquim Mullol, Laura Pujols, Isam Alobid, Maria Pérez-Gonzalez, Mireya Fuentes, Francisco de Borja Callejas, Antonio Valero, Cesar Picado & Jordi Roca-Ferrer. (2014) Fluticasone Furoate Inhibits Cytokine Secretion from Nasal Epithelial Cells and Reduces Eosinophil Survival in an in vitro Model of Eosinophilic Inflammation. International Archives of Allergy and Immunology 163:3, pages 225-233.
Crossref
W. Hamizan Aneeza, Salina Husain, Roslenda Abdul Rahman, Dexter Van Dort, Asma Abdullah & Balwant S. Gendeh. (2013) Efficacy of Mometasone Furoate and Fluticasone Furoate on Persistent Allergic Rhinoconjunctivitis. Allergy & Rhinology 4:3, pages ar.2013.4.0065.
Crossref
Mark Small, James Piercy, Pascal Demoly & Helen Marsden. (2013) Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey. Clinical and Translational Allergy 3:1, pages 33.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.